cbdMD (YCBD) Stock Overview
Produces and distributes various cannabidiol (CBD) products in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
YCBD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
cbdMD, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.59 |
| 52 Week High | US$6.54 |
| 52 Week Low | US$0.47 |
| Beta | 2.23 |
| 1 Month Change | 202.86% |
| 3 Month Change | 164.12% |
| 1 Year Change | -43.21% |
| 3 Year Change | -97.99% |
| 5 Year Change | -99.85% |
| Change since IPO | -99.85% |
Recent News & Updates
Recent updates
cbdMD (NYSEMKT:YCBD) Has Debt But No Earnings; Should You Worry?
Mar 23
This Insider Has Just Sold Shares In cbdMD, Inc. (NYSEMKT:YCBD)
Feb 23If You Had Bought cbdMD (NYSEMKT:YCBD) Stock A Year Ago, You Could Pocket A 383% Gain Today
Feb 09We Wouldn't Rely On cbdMD's (NYSEMKT:YCBD) Statutory Earnings As A Guide
Jan 13Is cbdMD (NYSEMKT:YCBD) Using Debt Sensibly?
Dec 15
Shareholder Returns
| YCBD | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -30.0% | 2.7% | 3.1% |
| 1Y | -43.2% | 25.1% | 14.6% |
Return vs Industry: YCBD underperformed the US Pharmaceuticals industry which returned 24.2% over the past year.
Return vs Market: YCBD underperformed the US Market which returned 14.2% over the past year.
Price Volatility
| YCBD volatility | |
|---|---|
| YCBD Average Weekly Movement | 48.6% |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: YCBD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: YCBD's weekly volatility has increased from 29% to 49% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 42 | T. Kennedy | www.cbdmd.com |
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products.
cbdMD, Inc. Fundamentals Summary
| YCBD fundamental statistics | |
|---|---|
| Market cap | US$14.98m |
| Earnings (TTM) | -US$4.38m |
| Revenue (TTM) | US$19.19m |
Is YCBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| YCBD income statement (TTM) | |
|---|---|
| Revenue | US$19.19m |
| Cost of Revenue | US$7.22m |
| Gross Profit | US$11.97m |
| Other Expenses | US$16.34m |
| Earnings | -US$4.38m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.46 |
| Gross Margin | 62.37% |
| Net Profit Margin | -22.80% |
| Debt/Equity Ratio | 0% |
How did YCBD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 14:33 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
cbdMD, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Hickey | Benchmark Company |
| William Sutherland | Benchmark Company |
| Anthony Vendetti | Maxim Group |